Amendment ID: S2133-1

Amendment 1

Synthetic Marijuana

Mr. Michael O. Moore moves to amend the bill by inserting, after section ____, the following new section:-

“SECTION  _____. Class C of section 31 of chapter 94C, as appearing in the 2012 Official Edition, is hereby amended by inserting after subsection (e) the following subsection:-

(f) Unless specifically excepted or listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any Cannabimimetic Agents that meet the criteria of any one or more of paragraphs (a) through (t) and any substance within the structural classes identified below that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays:

(a) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.

(b) 3-(1-naphthoyl)indole or 3-(1-naphthyl)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.

(c) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.

(d) 1-(1-naphthylmethyl)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.

(e) 3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.

Such Cannabimimetic Agents include, but are not limited to:

(i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497);

(ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog);

(iii) 1-pentyl-3-(1-naphthoyl) indole (JWH-018 and AM678);

(iv) 1-butyl-3-(1-naphthoyl) indole (JWH-073);

(v) 1-hexyl-3-(1-naphthoyl) indole (JWH-019);

(vi) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl) indole (JWH-200);

(vii) 1-pentyl-3-(2-methoxyphenylacetyl) indole (JWH-250);

(viii) 1-pentyl-3-[1-(4-methoxynaphthoyl)] indole (JWH-081);

(ix) 1-pentyl-3-(4-methyl-1-naphthoyl) indole (JWH-122);

(x) 1-pentyl-3-(4-chloro-1-naphthoyl) indole (JWH-398);

(xi) 1-(5-fluoropentyl)-3-(1-naphthoyl) indole (AM2201);

(xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl) indole (AM694);

(xiii) 1-pentyl-3-[(4-methoxy)-benzoyl] indole (SR-19 and RCS-4);

(xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl) indole (SR-18 and RCS-8); and

(xv) 1-pentyl-3-(2-chlorophenylacetyl) indole (JWH-203).”